|Videos|August 7, 2020
Expedited Programs for Drug Approvals
Advertisement
Pharmaceutical Executive’s Lisa Henderson interviews Todd Phillips, PharmD, of Cardinal Health Regulatory Sciences about FDA’s expedited programs and key elements to consider before using this pathway.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
3
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5